Physician profile
Jerome Wilson
NPI 1588765010
$515.54
in general payments reported to CMS, 2019-2025
11 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.77 · 2022: $18.60 · 2023: $184 · 2024: $33.93 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $138.29 | 2023 | Urolift |
| Progenics Pharmaceuticals, INC. | $119.89 | 2025 | |
| Janssen Biotech, INC. | $69.30 | 2025 | Rybrevant, Carvykti |
| Boston Scientific Corporation | $52.63 | 2023-2025 | Axonics, Rezum Generator |
| Myriad Genetic Laboratories, INC. | $29.42 | 2024-2025 | Prolaris |
| Astellas Pharma US INC | $20.60 | 2023 | Myrbetriq |
| Antares Pharma, INC. | $20.27 | 2024 | Xyosted |
| Urovant Sciences INC | $18.60 | 2022 | |
| Coloplast Corp | $16.79 | 2025 | |
| Tolmar, INC. | $14.98 | 2025 | Jatenzo, Eligard |
| Kci USA, INC. | $14.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.